Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edap Tms Sa ADR (NQ: EDAP )

9.000 -0.030 (-0.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 135,212
Open 8.600
Bid (Size) 3.640 (1)
Ask (Size) 10.30 (10)
Prev. Close 9.030
Today's Range 8.500 - 9.190
52wk Range 6.020 - 12.65
Shares Outstanding 36,910,925
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EDAP to Present at the Jefferies Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Recap: Edap TMS Q1 Earnings
 
Via Benzinga

Performance

YTD
-13.79%
-13.79%
1 Month
-20.00%
-20.00%
3 Month
-24.69%
-24.69%
6 Month
-18.92%
-18.92%
1 Year
+28.57%
+28.57%

More News

Read More
EDAP Announces First Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS Earnings Preview
Via Benzinga
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS's Earnings: A Preview
Via Benzinga
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
From EDAP TMS S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
From EDAP TMS S.A.
Via GlobeNewswire
7 Biotech Stocks Sitting in the Sweet Spot
Via InvestorPlace
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
EDAP Announces Record Q4 US Focal One Placements
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Via Benzinga
EDAP Reports Third Quarter 2022 Results
From EDAP TMS S.A.
Via GlobeNewswire
Earnings Outlook For Edap TMS
Via Benzinga
Earnings Scheduled For November 16, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.